2 completed, 1 enrolling by invitation, 1 unknown, 1 withdrawn. 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 4 | 1 | Withdrawn 1 |
Follow Strimvelis: new trials by email Literature Review of Strimvelis trials Research Report on Strimvelis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Methodology Study of Retroviral Insertion Site Analysis in Strimvelis Gene Therapy Strimvelis - Severe Combined Immunodeficiency Due to ADA Deficiency | Unknown | Fondazione Telethon | 15 | 2021-04-23 | 2024-01-29 | |
| Retroviral Insertion Site Methodology Study Strimvelis - Immune System Diseases | Phase 4 | Withdrawn | Fondazione Telethon | 2020-06-25 | 2024-01-29 | |
| Evaluating the Effectiveness of STRIMVELIS Risk Minimization Measures (RMMs) STRIMVELIS - Severe Combined Immunodeficiency Due to ADA Deficiency | Completed | Fondazione Telethon | 16 | 2018-04-12 | 2023-11-14 | |
| Strimvelis Registry Study to Follow-up Patients With Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID) Strimvelis - Immunologic Deficiency Syndromes | Enrolling by invitation | Fondazione Telethon | 50 | 2017-05-05 | 2026-05-22 | |
| ADA Gene Transfer Into Hematopoietic Stem/Progenitor Cells for the Treatment of ADA-SCID Gene Therapy, Busulfan - Immunologic Deficiency Syndromes | Phase 2 | Completed | Fondazione Telethon | 12 | 2002-10-02 | 2024-01-29 |
Severe combined immunodeficiency due to adenosine deaminase deficiency (4) · Immunologic Deficiency Syndromes (2) · Immune System Diseases (1) · Severe Combined Immunodeficiency (1)
Italy (4) · Israel (1)
PMID 38355973, PMID 18218852, PMID 19179314, PMID 19633200, PMID 19652199, PMID 22184407, PMID 27129325, PMID 28319446